View post: Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT™ and Virtue® SAB at CRT 2023
View post: Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT™ and Virtue® SAB at CRT 2023
Read the rest here: Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office
Read more here: Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
Read more: Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis
Follow this link: Press release: New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all...
See original here: ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on...
Read the original here: Bavarian Nordic to Host Full Year 2022 Results Conference Call
More: COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023
Read the original: TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Recent Comments